Histopathological Characteristics and Therapeutic Outcomes of Endoscopic Submucosal Dissection for Gastric High-Grade Intraepithelial Neoplasia

J Laparoendosc Adv Surg Tech A. 2022 Apr;32(4):413-421. doi: 10.1089/lap.2020.0035. Epub 2021 Dec 28.

Abstract

Background: The endoscopic resection of suspected gastric high-grade intraepithelial neoplasia (HGIN) may incidentally cause the patient to suffer from early gastric cancer (EGC), complicating the subsequent clinical management. Identifying the risk factors for such misstaging may help guide the clinical management. Methods: The information obtained from 123,460 patients, who underwent conventional upper gastrointestinal endoscopy at the First Affiliated Hospital of Nanjing Medical University from January 2010 to December 2015, were retrospectively reviewed. Patients with an initial diagnosis of HGIN underwent endoscopic submucosal dissection (ESD), and received a final diagnosis of EGC. The risk factors for the upgraded pathology and noncurative resection were analyzed. Results: Among the 134 patients initially diagnosed with HGIN, 35 (26.12%) patients were finally diagnosed with EGC after ESD. A lesion size of ≥2 cm (odds ratio [OR] = 5.16, 95% confidence interval [CI] = 2.04-13.05; P < .01), ≤4 biopsies taken (OR = 2.73, 95% CI = 1.15-6.48; P < .05), and the presence of upper gastrointestinal bleeding (UGIB; OR = 15.64, 95% CI = 1.29-189.75; P < .05) were the independent risk factors for upgraded pathology. In addition, patients >65 years old (OR = 0.022, 95% CI = 0.901-6.549; P < .05) or with a lesion size of ≥2 cm (OR = 4.237, 95% CI = 1.650-10.878; P < .01) were more likely to endure the noncurative resection. Conclusion: For suspected gastric HGIN patients, age, lesion size, the number of biopsies, and UGIB should be taken into account before deciding on the ESD.

Keywords: endoscopic submucosal dissection (ESD); follow-up; high-grade intraepithelial neoplasia (HGIN); noncurative resection; upgraded pathological diagnosis.

MeSH terms

  • Aged
  • Carcinoma in Situ* / etiology
  • Carcinoma in Situ* / pathology
  • Carcinoma in Situ* / surgery
  • Endoscopic Mucosal Resection* / adverse effects
  • Gastric Mucosa / pathology
  • Gastric Mucosa / surgery
  • Humans
  • Retrospective Studies
  • Stomach Neoplasms* / pathology
  • Treatment Outcome